Security National Bank Purchases New Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Security National Bank acquired a new stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 200 shares of the company’s stock, valued at approximately $54,000.

Other hedge funds also recently bought and sold shares of the company. Avantax Advisory Services Inc. raised its position in shares of HCA Healthcare by 33.4% during the 3rd quarter. Avantax Advisory Services Inc. now owns 4,305 shares of the company’s stock valued at $1,059,000 after buying an additional 1,079 shares during the period. Atria Wealth Solutions Inc. increased its position in shares of HCA Healthcare by 21.2% during the 3rd quarter. Atria Wealth Solutions Inc. now owns 1,678 shares of the company’s stock worth $413,000 after purchasing an additional 293 shares during the last quarter. D.A. Davidson & CO. boosted its stake in HCA Healthcare by 7.2% during the third quarter. D.A. Davidson & CO. now owns 5,551 shares of the company’s stock worth $1,365,000 after buying an additional 374 shares during the period. Van ECK Associates Corp purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $744,000. Finally, Pathstone Family Office LLC increased its holdings in HCA Healthcare by 248.3% in the 3rd quarter. Pathstone Family Office LLC now owns 6,520 shares of the company’s stock valued at $1,606,000 after purchasing an additional 4,648 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other HCA Healthcare news, SVP Chad J. Wasserman sold 344 shares of the company’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the sale, the senior vice president now owns 2,452 shares of the company’s stock, valued at $789,470.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the completion of the sale, the executive vice president now directly owns 34,124 shares in the company, valued at approximately $10,544,316. The disclosure for this sale can be found here. Insiders sold 13,617 shares of company stock valued at $4,321,986 in the last three months. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a research note on Wednesday, April 10th. Barclays raised their price objective on shares of HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research note on Monday, April 29th. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday. TD Cowen reduced their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research note on Tuesday, April 30th. Finally, Wells Fargo & Company upped their price target on HCA Healthcare from $303.00 to $315.00 and gave the stock an “equal weight” rating in a report on Thursday, March 28th. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $325.59.

Get Our Latest Research Report on HCA Healthcare

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $0.62 during midday trading on Friday, hitting $337.44. 908,281 shares of the company’s stock were exchanged, compared to its average volume of 959,017. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $340.00. The stock has a market cap of $88.38 billion, a price-to-earnings ratio of 16.82, a price-to-earnings-growth ratio of 1.56 and a beta of 1.69. The firm’s 50 day simple moving average is $319.40 and its 200 day simple moving average is $310.42. The company has a debt-to-equity ratio of 29.26, a quick ratio of 1.02 and a current ratio of 1.16.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping analysts’ consensus estimates of $5.01 by $0.35. The company had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The firm’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same period last year, the firm earned $4.93 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 20.86 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.78%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s payout ratio is 13.16%.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.